Latest Quarterly Activity Reports News

AVADA Group Limited reported a seasonally subdued quarter ending March 2025 but achieved positive operating cash flow through disciplined cost reductions and operational efficiencies. A strategic review of its New Zealand operations is underway amid challenging market conditions.

Hexima Limited reported a stable cash position of $1.55 million at quarter-end, with a modest $87,000 net cash outflow from operations. The biotech company continues to explore strategic opportunities while maintaining a strong funding runway.

Skin Elements Limited advances its natural biotechnology products with ECO-Nurture trials concluding and SuprCuvr disinfectant gaining traction, supported by a successful $656k capital raise.

Toro Energy has completed a re-optimisation of its Lake Maitland mining pit at the Wiluna Uranium Project, integrating updated uranium and vanadium resource estimates and rising cost assumptions. The company is progressing a scoping study update while engaging with native title groups, positioning itself amid strengthening uranium market conditions.

Freehill Mining reported a seasonal slowdown in sales and logistical challenges in Q3 FY2025 but strengthened its position with a new site acquisition and a $700,000 capital raise to fuel growth in Chile’s construction materials market.

Manhattan Corporation reports strong exploration progress at its Tibooburra Gold and Chebogue Lithium projects, backed by a solid cash position and no debt.

Energy Technologies Limited reported a 6.8% decline in quarterly cash receipts and a 37.5% rise in net operating outflows for 3Q FY2025, prompting a strategic review of its capital structure to support future growth.

KGL Resources has reported a robust quarterly update for its Jervois Copper Project, highlighting a strong feasibility study with a $405 million NPV and successful drilling that extends high-grade copper resources. The company also secured $4.2 million in new capital and is progressing strategic financing to target production by 2027.

Austral Gold’s Q1 2025 report reveals a 15.4% drop in gold equivalent production at its Guanaco mine due to mine depletion and mill repairs, while refurbishment advances at Casposo aim to boost future output.

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Uvre Limited reported steady progress in its uranium and lithium exploration projects during the March 2025 quarter, completing Phase 2 geophysical surveys and advancing joint venture discussions while maintaining solid cash reserves.

Cluey Ltd reported a 24% surge in new student enrolments in Q3 FY25 alongside a 46% reduction in cash burn, signaling improved operational efficiency and a clearer path to profitability.